W

Wave Life Sciences USA

Clinical-stage biotech developing stereopure oligonucleotides

Quality Control Co-op

Regulatory & Quality (Life Sciences)Confirmed live in the last 24 hours
Internship · Spring 2027Lexington, MA, USA

About the Job

Requirements

  • The candidate must be working toward a bachelor's degree in chemistry or a related discipline, such as biochemistry or chemical engineering.
  • At least two years of undergraduate education in a related discipline must be completed.
  • The intern must have successfully completed chemistry courses.
  • The candidate must have hands-on experience with basic wet chemistry, sampling, testing organic or inorganic compounds, and other laboratory techniques.
  • The candidate must have analytical chemistry laboratory skills and analytical chemistry knowledge.
  • The candidate must have strong oral and written communication skills and organizational skills.

Responsibilities

  • Perform analytical testing of in-process materials, finished product (API), and raw materials.
  • Analyze research and production samples.
  • Document and organize data sets and report results to other departments.
  • Troubleshoot analyses and assist in conducting investigations.
  • Assist with procurement and tracking of reagents and materials.
  • Review data generated by other analysts.
  • Execute method qualifications and validations.

Desired Qualifications

  • Experience with HPLC, Karl Fischer moisture analysis, UV-Vis spectroscopy, microbiology testing, FTIR spectroscopy, chemical synthesis, or purification processes.

About the Company

Wave Life Sciences USA

Clinical-stage biotech developing stereopure oligonucleotides

Wave Life Sciences develops stereopure nucleic acid therapies for genetically defined diseases. Its PRISM platform designs stereopure oligonucleotides that enable RNA interference, antisense silencing, splicing modulation, and RNA editing, including AIMers that recruit ADAR enzymes to edit RNA without changing the DNA. The company funds R&D mainly through partnerships and licensing (notably with GSK) and has programs in conditions like Alpha-1 antitrypsin deficiency, Duchenne muscular dystrophy, Huntington’s disease, and obesity. Its goal is to bring approved RNA medicines to patients by advancing a diversified pipeline and sustaining long-term collaborations that fund development.

Company size
201-500
Company stage
IPO
Headquarters
Cambridge, MA
Founded
2012

Recently Posted Jobs

Explore more opportunities at Wave Life Sciences USA

See more jobs